伊之密(300415.SZ):伊之密注壓擬向銀行申請5.95億元綜合授信額度
格隆匯7月5日丨伊之密(300415.SZ)公佈,為增強公司的生產能力,擴大生產規模,提高公司的經濟效益,公司決定建設廣東伊之密注壓科技有限公司(公司全資子公司,“伊之密注壓”)順德科技工業園A區西-10-1地塊工業項目。為了滿足伊之密注壓新建生產基地的資金需求,伊之密注壓擬向中國農業銀行股份有限公司順德容桂支行申請人民幣5.95億元的綜合授信額度,融資期限為15年,伊之密注壓擬以項目自有用地及上蓋物為上述融資提供抵押擔保,公司同時為上述融資提供連帶責任保證擔保,具體融資及擔保的金額以伊之密注壓、公司與中國農業銀行股份有限公司順德容桂支行簽訂的借款合同和擔保合同上載明的金額為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.